Oral anticoagulant discontinuation in patients with nonvalvular atrial fibrillation.

Abstract

The risk of independent discontinuation of OAC treatment among NVAF patients was high. Patients on DOACs compared with warfarin and those with several comorbid conditions had significantly lower risk of discontinuation, while those with prior bleeding were more likely to discontinue.